Brian O’Callaghan stepped down as CEO effective February 23, 2023, with Will Brown, current CFO, appointed as Interim CEO, while also retaining the title of Chief Financial Officer. Additionally, Clive Bertram, Chief Commercial Officer, Brandi Howard, Chief Clinical Officer, and Luigi Marro, Chief Transformation Officer also departed the Company effective February 23, 2023. The Company has initiated a search for a permanent CEO to be based in Geneva, Switzerland.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OBSV:
